Mechanism of Helicobacter pylori pathogenesis: focus on mucus
- PMID: 1378466
Mechanism of Helicobacter pylori pathogenesis: focus on mucus
Abstract
Although the clinical data provide increasingly convincing indications that Helicobacter pylori (H. pylori) is a causative factor in gastritis and peptic ulcer, the advances toward the clear understanding of this bacterium's pathogenic action are slow in coming. Having a niche bordering two major perimeters of gastric mucosal defense, H. pylori is capable of exerting detrimental effects on the mucus layer, as well as surface cells of the gastric epithelium. To cause such an effect, the bacteria must first, however, attach to the mucosa. Our findings indicate that this attachment involves specific structures on the epithelial cell surfaces, namely lactosylceramide sulfate and GM3 ganglioside. The analysis of the glycolipid distribution pattern in different regions of human stomach revealed that the antral mucosal content of GM3 and lactosylceramide sulfate are considerably higher than that of the fundus, which may account for the prevalence of H. pylori colonization of the antrum. We have also established that H. pylori causes considerable untoward changes in gastric mucus coat integrity. These changes are reflected in the loss of protective qualities of mucus due to the action of H. pylori-elaborated proteases and lipases. The result of H. pylori protease action is disintegration of the polymeric structure of mucin, whereas the elaborated lipases and phospholipase A2 in particular result in mucus lipid degradation, loss of mucosal surface, hydrophobicity, and lysophospholipid generation. The lytic activity of the resulting lysophospholipids is detrimental not only to mucus gel integrity, but even more so to the cell membrane of gastric epithelium.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.Arzneimittelforschung. 1997 Apr;47(4A):475-82. Arzneimittelforschung. 1997. PMID: 9205747 Review.
-
Mucus and H. pylori.J Physiol Pharmacol. 1997 Sep;48(3):297-305. J Physiol Pharmacol. 1997. PMID: 9376612 Review.
-
Role of mucus in gastric mucosal protection.J Physiol Pharmacol. 1991 Jun;42(2):147-61. J Physiol Pharmacol. 1991. PMID: 1782415 Review.
-
Morphological aspects of the cytotoxic action of Helicobacter pylori.Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S17-21. Eur J Gastroenterol Hepatol. 1994. PMID: 7537615
-
Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone.Biochem Int. 1992 May;26(6):1091-9. Biochem Int. 1992. PMID: 1632804
Cited by
-
Computational modeling of complex bioenergetic mechanisms that modulate CD4+ T cell effector and regulatory functions.NPJ Syst Biol Appl. 2022 Nov 22;8(1):45. doi: 10.1038/s41540-022-00263-4. NPJ Syst Biol Appl. 2022. PMID: 36418318 Free PMC article.
-
Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells.Infect Immun. 2000 Jun;68(6):3172-9. doi: 10.1128/IAI.68.6.3172-3179.2000. Infect Immun. 2000. PMID: 10816460 Free PMC article.
-
Phospholipase A of Yersinia enterocolitica contributes to pathogenesis in a mouse model.Infect Immun. 1998 Aug;66(8):3941-51. doi: 10.1128/IAI.66.8.3941-3951.1998. Infect Immun. 1998. PMID: 9673284 Free PMC article.
-
Helicobacter pylori infection does not reduce the viscosity of human gastric mucus gel.Gut. 1995 Mar;36(3):327-9. doi: 10.1136/gut.36.3.327. Gut. 1995. PMID: 7698685 Free PMC article.
-
Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.Gut. 2000 Oct;47(4):589-94. doi: 10.1136/gut.47.4.589. Gut. 2000. PMID: 10986224 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical